Category:
Bio Products
CAS NO:
/
Standard:
In-house Standards,
Please contact us for more details
Recombinant Human Thrombopoietin Injection is a biopharmaceutical agent produced via recombinant DNA technology in mammalian cells to stimulate megakaryocyte proliferation. It mimics endogenous thrombopoietin function, crucial for platelet production regulation.
Contraindicated in patients with hypersensitivity to the product or E. coli-derived proteins. Requires refrigeration at 2°C–8°C; avoid freezing. Monitor platelet counts closely to prevent thrombotic risks.